DE602004029362D1 - Vermeidung von vorhofflimmern (af) mit der verwendung von statin - Google Patents
Vermeidung von vorhofflimmern (af) mit der verwendung von statinInfo
- Publication number
- DE602004029362D1 DE602004029362D1 DE602004029362T DE602004029362T DE602004029362D1 DE 602004029362 D1 DE602004029362 D1 DE 602004029362D1 DE 602004029362 T DE602004029362 T DE 602004029362T DE 602004029362 T DE602004029362 T DE 602004029362T DE 602004029362 D1 DE602004029362 D1 DE 602004029362D1
- Authority
- DE
- Germany
- Prior art keywords
- statin
- avoidance
- promotion
- attenuate
- previous labels
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 title abstract 2
- 206010003658 Atrial Fibrillation Diseases 0.000 abstract 3
- 206010003668 atrial tachycardia Diseases 0.000 abstract 2
- 241000282472 Canis lupus familiaris Species 0.000 abstract 1
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 abstract 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000007634 remodeling Methods 0.000 abstract 1
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 abstract 1
- 229960002855 simvastatin Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Catching Or Destruction (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47914703P | 2003-06-18 | 2003-06-18 | |
| PCT/CA2004/000911 WO2004110427A1 (en) | 2003-06-18 | 2004-06-18 | Preventing atrial fibrillation (af) with the use of statin drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004029362D1 true DE602004029362D1 (de) | 2010-11-11 |
Family
ID=33551865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004029362T Expired - Lifetime DE602004029362D1 (de) | 2003-06-18 | 2004-06-18 | Vermeidung von vorhofflimmern (af) mit der verwendung von statin |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060178424A1 (de) |
| EP (1) | EP1638548B1 (de) |
| AT (1) | ATE482698T1 (de) |
| CA (1) | CA2529367C (de) |
| DE (1) | DE602004029362D1 (de) |
| WO (1) | WO2004110427A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9072816B2 (en) * | 2006-01-18 | 2015-07-07 | Cormatrix Cardiovascular, Inc. | Composition for modulating inflammation of cardiovascular tissue |
| US9532943B2 (en) | 2010-12-20 | 2017-01-03 | Cormatrix Cardiovascular, Inc. | Drug eluting patch for the treatment of localized tissue disease or defect |
| US8962324B2 (en) | 2006-01-18 | 2015-02-24 | Cormatrix Cardiovascular, Inc | Method and system for treatment of biological tissue |
| DK2398502T3 (en) * | 2009-02-18 | 2015-11-23 | Cormatrix Cardiovascular Inc | FORMATIONS AND PROCESSES FOR PREVENTING cardiac arrhythmia |
| KR20140005920A (ko) * | 2010-12-20 | 2014-01-15 | 코매트릭스 카디오바스컬라 인코포레이티드 | 국부화된 조직 질병 또는 결함의 치료를 위한 약물 용출 패치 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS591415A (ja) * | 1982-06-28 | 1984-01-06 | Mochida Pharmaceut Co Ltd | 循環系疾患治療剤 |
| FR2751540B1 (fr) * | 1996-07-26 | 1998-10-16 | Sanofi Sa | Composition pharmaceutique antithrombotique |
| US6235311B1 (en) * | 1998-03-18 | 2001-05-22 | Bristol-Myers Squibb Company | Pharmaceutical composition containing a combination of a statin and aspirin and method |
| WO2001021163A2 (en) * | 1999-09-21 | 2001-03-29 | Emory University | Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents |
-
2004
- 2004-06-18 DE DE602004029362T patent/DE602004029362D1/de not_active Expired - Lifetime
- 2004-06-18 US US10/561,162 patent/US20060178424A1/en not_active Abandoned
- 2004-06-18 CA CA2529367A patent/CA2529367C/en not_active Expired - Fee Related
- 2004-06-18 AT AT04737850T patent/ATE482698T1/de not_active IP Right Cessation
- 2004-06-18 EP EP04737850A patent/EP1638548B1/de not_active Expired - Lifetime
- 2004-06-18 WO PCT/CA2004/000911 patent/WO2004110427A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| ATE482698T1 (de) | 2010-10-15 |
| WO2004110427A1 (en) | 2004-12-23 |
| EP1638548A1 (de) | 2006-03-29 |
| US20060178424A1 (en) | 2006-08-10 |
| EP1638548B1 (de) | 2010-09-29 |
| CA2529367A1 (en) | 2004-12-23 |
| CA2529367C (en) | 2012-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0413468A (pt) | inibidores de hmg-coa redutase baseados em pirrol | |
| EA200601457A1 (ru) | Ингибиторы вирусной полимеразы | |
| AR062794A1 (es) | Composiciones y metodos para el tratamiento de enfermedades virales | |
| CY1110064T1 (el) | Παραγωγα φαινυλ-πιπεραζινης ως αναστολεις επαναπροσληψης σεροτονινης | |
| DE60313472D1 (de) | Pyrrolidindion-substituierte piperidin-phthalazone als pde4-inhibitoren | |
| CY1109006T1 (el) | Παραγωγα πουρινης ως αναστολεις κινασης | |
| ATE501126T1 (de) | Verfahren zur herstellung von rosuvastatin | |
| DE69912581D1 (de) | Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren | |
| DE60319364D1 (de) | Substituierte pyrroline als kinase inhibitoren | |
| DE60305061D1 (de) | 2-pyridonderivate als inhibitoren von neutrophiler elastase | |
| BRPI0720525B8 (pt) | inibidores de mapk/erk quinase | |
| ATE495162T1 (de) | Azabicyclo-octan und nonan derivate mit ddp-iv hemmender wirkung | |
| ATE479687T1 (de) | Kinaseinhibitoren | |
| DE60306547D1 (de) | Substituierte 3-alkyl- und 3-arylalkyl-1h-indol-1-yl-essigsäure-derivate als plasminogen aktivator inhibitor-1 (pai-1) inhibitoren | |
| ATE409035T1 (de) | Substituierte pyrroline als kinase inhibitoren | |
| BR0211274A (pt) | Combinação de um antagonista de receptor de aldosterona e um inibidor de hmg co-a redutase | |
| BRPI0509926A (pt) | imidazóis | |
| ATE519849T1 (de) | Herstellung von pravastatin | |
| ATE496025T1 (de) | Magnesiumsalze von hmg-coa-reduktase-hemmern | |
| ATE496109T1 (de) | Umsetzungsprodukte von mercaptobenzothiazolen, mercaptothiazolinen und mercaptobenzimidazolen mit epoxiden als schmiermitteladditive | |
| EA200400200A1 (ru) | Молекулярные метки для систем органических растворителей | |
| DE602004029362D1 (de) | Vermeidung von vorhofflimmern (af) mit der verwendung von statin | |
| CR9521A (es) | Metodo novedoso de tratamiento de la hiperlipedemia | |
| DE60327936D1 (de) | Modulatoren von ship-1 | |
| DK1478650T3 (da) | Nye boronatestere |